- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 2 x MN: MANGANESE (II) ION(Non-covalent)
- 1 x ZW2: 6-benzyl-3-hydroxythieno[2,3-d]pyrimidine-2,4(1H,3H)-dione(Non-covalent)
- 35 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 4 residues within 4Å:- Chain A: D.123, E.124, D.125
- Ligands: EDO.5
Ligand excluded by PLIPEDO.5: 6 residues within 4Å:- Chain A: P.11, V.12, K.13, D.123, D.125
- Ligands: EDO.4
Ligand excluded by PLIPEDO.6: 8 residues within 4Å:- Chain A: L.102, K.103, K.104, K.105, V.108, Y.190, L.236, Y.320
Ligand excluded by PLIPEDO.7: 3 residues within 4Å:- Chain A: Y.185, D.187, D.188
Ligand excluded by PLIPEDO.8: 4 residues within 4Å:- Chain A: Q.342, Y.344, F.348, N.350
Ligand excluded by PLIPEDO.9: 7 residues within 4Å:- Chain A: T.379, I.382
- Chain B: W.25, P.26, E.400, T.401
- Ligands: PGE.28
Ligand excluded by PLIPEDO.10: 4 residues within 4Å:- Chain A: Q.502
- Chain B: N.266, W.267, Q.270
Ligand excluded by PLIPEDO.11: 6 residues within 4Å:- Chain A: G.438, A.439, E.440, N.462, K.463
- Chain B: A.289
Ligand excluded by PLIPEDO.12: 2 residues within 4Å:- Chain A: P.16, M.18
Ligand excluded by PLIPEDO.13: 3 residues within 4Å:- Chain A: P.3, I.4, G.215
Ligand excluded by PLIPEDO.14: 2 residues within 4Å:- Chain A: P.6, E.8
Ligand excluded by PLIPEDO.15: 6 residues within 4Å:- Chain A: V.12, K.13, L.14, D.125, F.126, Y.129
Ligand excluded by PLIPEDO.16: 4 residues within 4Å:- Chain A: D.19, K.22, P.57, Y.58
Ligand excluded by PLIPEDO.17: 4 residues within 4Å:- Chain A: N.56, P.57, N.59, R.145
Ligand excluded by PLIPEDO.18: 1 residues within 4Å:- Chain A: E.31
Ligand excluded by PLIPEDO.19: 3 residues within 4Å:- Chain A: S.50, K.51, I.52
Ligand excluded by PLIPEDO.20: 3 residues within 4Å:- Chain A: R.80, N.83, K.84
Ligand excluded by PLIPEDO.21: 5 residues within 4Å:- Chain A: Y.117, Q.153, G.154, S.158, P.159
Ligand excluded by PLIPEDO.22: 6 residues within 4Å:- Chain A: G.446, N.476, E.480
- Ligands: MN.1, ZW2.3, EDO.23
Ligand excluded by PLIPEDO.23: 6 residues within 4Å:- Chain A: E.480, D.500, S.501, Y.503
- Ligands: ZW2.3, EDO.22
Ligand excluded by PLIPEDO.24: 6 residues within 4Å:- Chain A: Y.429, Q.430, L.527, K.530, E.531, V.533
Ligand excluded by PLIPEDO.25: 2 residues within 4Å:- Chain A: P.6, R.213
Ligand excluded by PLIPEDO.26: 3 residues within 4Å:- Chain A: E.91, Q.163, Y.185
Ligand excluded by PLIPEDO.29: 6 residues within 4Å:- Chain B: I.64, K.65, T.404, E.405, W.407, Q.408
Ligand excluded by PLIPEDO.30: 5 residues within 4Å:- Chain B: R.79, E.400, W.403, W.415
- Ligands: PGE.28
Ligand excluded by PLIPEDO.31: 3 residues within 4Å:- Chain B: K.14, Q.86, D.87
Ligand excluded by PLIPEDO.32: 4 residues within 4Å:- Chain B: K.102, V.242, L.350, K.351
Ligand excluded by PLIPEDO.33: 6 residues within 4Å:- Chain B: K.66, V.109, L.110, D.111, D.187, M.231
Ligand excluded by PLIPEDO.34: 3 residues within 4Å:- Chain B: T.287, K.288, E.292
Ligand excluded by PLIPEDO.35: 5 residues within 4Å:- Chain B: Q.279, E.299, L.302, E.303, E.306
Ligand excluded by PLIPEDO.36: 6 residues within 4Å:- Chain B: Y.233, L.235, W.240, Y.355, K.375, E.379
Ligand excluded by PLIPEDO.37: 3 residues within 4Å:- Chain B: K.396, E.397, E.400
Ligand excluded by PLIPEDO.38: 5 residues within 4Å:- Chain A: E.434, P.435, V.437
- Chain B: T.254, T.291
Ligand excluded by PLIPEDO.39: 4 residues within 4Å:- Chain B: Y.184, K.386, T.387, K.389
Ligand excluded by PLIPEDO.40: 6 residues within 4Å:- Chain B: E.329, I.330, Q.331, K.391, V.418, T.420
Ligand excluded by PLIP- 2 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
PGE.27: 13 residues within 4Å:- Chain B: L.75, V.76, D.77, F.78, R.79, N.82, G.153, Y.184, M.185, T.387, W.411, I.412, P.413
7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:F.78, B:N.82, B:Y.184
- Water bridges: B:V.76, B:Q.152, B:Q.152, B:T.410
PGE.28: 8 residues within 4Å:- Chain B: W.25, E.400, T.401, W.402, W.403, T.404
- Ligands: EDO.9, EDO.30
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:W.402, B:T.404, B:E.405
- Water bridges: B:E.400, B:E.405
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kankanala, J. et al., Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H. Eur J Med Chem (2017)
- Release Date
- 2018-08-08
- Peptides
- Reverse transcriptase/ribonuclease H: A
p51 RT: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 2 x MN: MANGANESE (II) ION(Non-covalent)
- 1 x ZW2: 6-benzyl-3-hydroxythieno[2,3-d]pyrimidine-2,4(1H,3H)-dione(Non-covalent)
- 35 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kankanala, J. et al., Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H. Eur J Med Chem (2017)
- Release Date
- 2018-08-08
- Peptides
- Reverse transcriptase/ribonuclease H: A
p51 RT: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D